Life Technologies today unveiled a "streamlined" program for detecting three common contaminants of mammalian cell culture-based biopharmaceutical manufacturing.

The new Applied Biosystems Cell Culture Rapid Methods Program applies core technologies from across the company to combine one sample-preparation step with one instrument platform for real-time PCR based detection of Mycoplasma, vesivirus 2117, and mouse minute virus.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.